Romosozumab rescues impaired bone mass and strength in a murine model of diabetic kidney diseaseRachel Kohler(University of Indianapolis), Joseph M. Wallace(Indiana University – Purdue University Indianapolis)Bone ReportsMay 12, 202410.1016/j.bonr.2024.101774Cited by 5SaveCiteExport RISWatch citationsRelated PapersHigh glucose-induced inhibition of osteoblast like MC3T3-E1 differentiation promotes mitochondrial perturbations|PLoS ONE|2022|28A novel murine model of combined insulin-dependent diabetes and chronic kidney disease has greater skeletal detriments than either disease individually|Bone|2022|8Metabolic and Skeletal Characterization of the KK/Ay Mouse Model—A Polygenic Mutation Model of Obese Type 2 Diabetes|Calcified Tissue International|2024|3